Bulk Taranjabin Persian Manna

Research & Studies on Taranjabin (Persian Manna)

Taranjabin (Persian Manna / Manna of Hedysarum / Camel Thorn Manna)
Alhagi pseudalhagi (M.Bieb.) Desv. ex Wangerin – family Fabaceae

1. Botanical and traditional background

Taranjabin (also written Taranjebin or Tarangabin) is the sweet, resinous manna that forms as small yellowish tear-shaped droplets (1–3 mm) on the aerial parts of Alhagi species such as Alhagi pseudalhagi / Alhagi maurorum (camel thorn). It is produced when the froghopper Poophilus nebulosus feeds on the plant and excretes a sugary exudate that crystallises on stems and leaves. ResearchGate+1

A comprehensive overview of Alhagi maurorum lists multiple synonyms (including Alhagi pseudalhagi and Hedysarum alhagi), and describes this shrub as native to the Middle East and Central Asia but now distributed across Europe, North Africa (including South Africa), North America (USA) and Australia. ResearchGate In these regions, the plant and its manna are known under names such as “camel thorn,” “Caspian manna,” and “Persian manna plant,” and are traditionally used as mild laxatives, diuretics, expectorants and sweeteners. ResearchGate+1

In Persian traditional medicine, Taranjabin is described as a gentle laxative, sweetener and demulcent, widely used in children for constipation, mild fever and as part of herbal combinations for neonatal jaundice. ResearchGate+1 It is also recorded as an ingredient in formulations for respiratory and gastrointestinal complaints. ResearchGate

2. Composition and physicochemical properties

Recent analytical work and meta-analyses confirm that Taranjabin is a carbohydrate-rich manna with additional polyphenols, mucilage and minerals that are relevant for food, nutraceutical and pharmaceutical industries.

• A 2024 techno-functional study on Iranian Tarangabin from Alhagi pseudalhagi reported ≈92–93% carbohydrates, with low fat and ash, and highlighted strong foaming (≈77%) and foaming stability (≈92%), good emulsifying activity and Newtonian flow behaviour. The authors concluded that Tarangabin “holds potential as a special food ingredient” due to its sweetness, characteristic flavour and functional properties. ResearchGate Full text: https://doi.org/10.1155/2024/6610629

• A 2025 meta-analysis of published composition data for manna from Alhagi maurorum found that Tarangabin typically contains around 720 mg/g total carbohydrates, mainly glucose (~250 mg/g), fructose (~250 mg/g), sucrose (~150 mg/g) and the trisaccharide melezitose (~47.7 mg/g). It also contains the sugar alcohol mannitol (~150 mg/g), mucilage (~150 mg/g), tannins, anthocyanins, flavonoids (e.g. quercetin and isorhamnetin glycosides) and minerals such as calcium, potassium, magnesium, iron and zinc.

• A broader phytochemical review of Alhagi spp. confirms the presence of flavonoids, triterpenes, sterols, tannins, sugars and mucilage in different plant parts and manna, supporting antioxidant, anti-inflammatory and gastrointestinal applications. Journal of Herbmed Pharmacology+1 Review: https://herbmedpharmacol.com/Article/jhp-7344

These data are important for positioning bulk Taranjabin Persian Manna as a naturally sweet, functionally active raw material for herbal syrups, gentle laxatives, pediatric products, nutraceuticals and functional food formulations in export markets.

3. Pharmacological and clinical research

3.1 Mild laxative and gastrointestinal effects

Traditional sources consistently describe Taranjabin as a mild laxative and gastrointestinal remedy, particularly suitable for children. ResearchGate+1 Modern reviews of Alhagi spp. and Tarangabin summarise: Journal of Herbmed Pharmacology+1

• Laxative effect attributed to high levels of osmotically active sugars (glucose, fructose, sucrose) and mannitol, which increase stool water content and motility. hamed-biglari.ir+1

• Anti-ulcer and mucosal protection linked to its mucilage fraction, which can coat and soothe the gastrointestinal lining in experimental models. hamed-biglari.ir+1

• Antidiarrhoeal / astringent effects plausibly related to tannins and polyphenols in certain preparations. hamed-biglari.ir+1

This dual profile (mild osmotic laxative plus demulcent) is of interest for manufacturers seeking bulk Taranjabin for gentle laxative formulations, especially in regions where traditional Persian and Middle Eastern medicines are integrated with modern herbal practice.

3.2 Neonatal jaundice and pediatric applications

A number of Iranian clinical and observational studies have evaluated Taranjabin and related manna-based remedies as adjuncts in neonatal jaundice management: PMC+2

• Historical randomized and controlled studies investigated oral Taranjebin as a prophylactic or adjunctive agent alongside standard phototherapy for term neonates with non-hemolytic hyperbilirubinemia. These trials reported bilirubin reductions and shorter hospital stay in some groups, but sample sizes were modest and protocols heterogeneous. PMC+2

• Reviews on manna-based phytotherapy in Iranian neonates conclude that, while traditional use is widespread, more rigorous, standardised clinical trials are required before firm recommendations can be made. PMC+1

For global markets (UK, USA, Canada, Australia, New Zealand, South Africa), these data position Taranjabin as a traditional pediatric ingredient that may inspire R&D for pediatric syrups and gentle herbal formulations, always subject to local regulatory frameworks and clinical safety assessment.

3.3 Immunomodulatory properties

A 2015 study on the immunomodulatory properties of Taranjebin manna and its isolated polysaccharide macromolecules found that: ResearchGate+1

• ~92% of Taranjebin is water-soluble, yielding several purified carbohydrate biopolymers.

• Certain fractions modulated proliferation of human Jurkat T-cells in vitro, indicating potential immune-modulating activity without overt cytotoxicity at tested concentrations.

The authors concluded that Taranjabin contains polysaccharides with immunomodulatory potential, supporting its historical use in infectious and febrile conditions, though they emphasised the need for further in vivo and clinical work. ResearchGate+1

This line of research is relevant for nutraceutical and functional food companies looking at bulk Persian manna for immune-support concepts, particularly in the USA, Canada and EU markets where interest in immune-focused botanicals remains high.

3.4 Kidney and metabolic support

A randomized controlled trial published in Avicenna Journal of Phytomedicine (2020) evaluated camel milk plus Tarangabin (manna of Alhagi maurorum) as an adjunct therapy in patients with chronic kidney disease (CKD), compared to conventional treatment alone. PubMed+1 Free full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC7164448/

• The combination therapy improved estimated glomerular filtration rate (eGFR) and some biochemical markers versus control over the study period.

• The trial suggests potential nephro-supportive effects when Taranjabin is used in combination with other functional ingredients, though confirmatory trials are still needed. PubMed+1

These findings may be of interest to specialised nutraceutical and functional beverage brands evaluating bulk Taranjabin Persian Manna as part of kidney-support or metabolic health formulations, always within regulatory limits on health claims.

4. Alhagi extracts beyond manna: anti-inflammatory and antimicrobial potential

Research on Alhagi pseudalhagi and A. maurorum extracts (beyond the manna itself) broadens the scientific basis for using Taranjabin-related raw materials:

• A 2021 Frontiers in Pharmacology article reported that Alhagi pseudalhagi extract protected against experimental ulcerative colitis in mice by modulating TLR4-dependent NF-κB signalling, reducing inflammatory cytokines and histological damage. Frontiers Full text: https://www.frontiersin.org/articles/10.3389/fphar.2021.764602/full

• Reviews and experimental studies show antimicrobial, antiprotozoal and antifungal activities from various Alhagi extracts, with activity against Staphylococcus aureus, Escherichia coli and several plant pathogenic fungi. Flora Journal+1

While these data relate primarily to plant extracts rather than pure manna, they strengthen the overall positioning of Alhagi-derived ingredients (including Persian manna) in pharmaceutical, veterinary, cosmetic and agricultural innovation pipelines across the UK, EU, North America and Australia.

5. Safety considerations

Traditional texts typically describe Taranjabin as safe at moderate doses (20–150 g, depending on indication), but they also list contraindications in acute febrile illnesses, measles, smallpox, dysentery and hemorrhagic conditions. ResearchGate+1

Modern sources add:

• An experimental toxicity study in rats found potential adverse effects at high doses of camel thorn preparations, underlining the importance of dose control. PMC+1

• Reviews stress that, despite extensive traditional use, clinical data on long-term safety, paediatric dosing and interactions remain limited, and that further well-designed human trials are necessary. Journal of Herbmed Pharmacology+1

For buyers seeking to buy Taranjabin in bulk from an export-quality camel thorn manna supplier, these findings support its use as a traditional ingredient, but also highlight the need for products to be developed under appropriate regulatory oversight in each target market.

6. Commercial relevance for key regions

Although most experimental and clinical research on Taranjabin has been conducted in Iran and neighbouring countries, the work is published in international journals indexed and used by researchers and formulators in the United Kingdom, USA, Canada, Australia, New Zealand and South Africa. Journal of Herbmed Pharmacology+1

This scientific base supports commercial development in several directions:

• Functional and herbal syrups:

  • Using bulk Taranjabin Persian Manna for herbal syrup production targeting gentle laxative, demulcent and digestive-comfort positioning.

• Pediatric and family herbal products:

  • Development of carefully formulated products that build on Taranjabin’s traditional pediatric use, always aligned with local paediatric guidelines.

• Nutraceuticals and functional foods:

  • Incorporating Taranjabin as a natural camel thorn manna sweetener with prebiotic-like carbohydrate profile and polyphenols for functional beverages, wellness shots and powders.

• Pharmaceutical and cosmetic use:

  • Exploiting demulcent, antioxidant and potential immunomodulatory activities in lozenges, throat preparations and skin-soothing formulations, in combination with other botanicals.

Scientific and traditional data on Taranjabin support its use in a range of applications, from bulk Taranjabin Persian Manna for herbal syrup production and bulk Taranjabin for gentle laxative formulations to bulk Persian manna for pediatric formulations, nutraceuticals and functional foods. International buyers looking to buy Taranjabin in bulk from an export-quality camel thorn manna supplier and Persian manna ingredient suppliers worldwide can use these studies to justify product development and innovation in the functional food, pharmaceutical and wellness sectors.